IV lignocaine 'superior to fentanyl' in angiography: trial
Lignocaine circumvents the impairment of ticagrelor seen with opioid analgesia, cardiologist says
AusDoc brings you the latest news from the Cardiac Society of Australia and New Zealand virtual annual scientific meeting, CSANZ 2021.
Routine use of opioids for pain relief during certain coronary interventions might need to be reconsidered as lignocaine is likely a better alternative, CSANZ 2021 has heard.
In the LOCAL trial, 70 patients undergoing coronary angiography at the Alfred Hospital in Melbourne and indicated to receive ticagrelor were
